Interní Med. 2011; 13(2): 75-77

Viral hemorrhagic fevers - yesterdey and tomorrow

RNDr.Vanda Boštíková, Ph.D.1, MUDr.Jan Smetana, Ph.D.1, doc.MUDr.Roman Chlíbek, Ph.D.1, prof.MUDr.Miroslav Špliňo, DrSc.1, RNDr.Marie Vacková, CSc.1, RNDr.Irena Hanovcová, CSc.1, doc.MUDr.Pavel Boštík, Ph.D.2
1 Katedra epidemiologie, Fakulta vojenského zdravotnictví Univerzity obrany, Hradec Králové
2 Centrum pokročilých studií, Fakulta vojenského zdravotnictví Univerzity obrany, Hradec Králové

Viral hemorrhagic fevers represent a collection of illnesses caused by several distinct viral families. While some types of hemorrhagic fever

viruses can cause relatively mild illnesses, many of these viruses cause life-threatening diseases. In general; the term „viral hemorrhagic

fever“ describes a severe multisystem syndrome. Typical for this syndrome is a systemic damage of vascular system often accompanied

by hemorrhages. Nevertheless the bleeding itself is rarely life-threatening.

Keywords: viral hemorrhagic fevers, RNA viruses, reservoir, vector

Published: February 21, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Boštíková V, Smetana J, Chlíbek R, Špliňo M, Vacková M, Hanovcová I, Boštík P. Viral hemorrhagic fevers - yesterdey and tomorrow. Interní Med. 2011;13(2):75-77.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Peters CJ, Jahrling PB, Khan AS. Patiens infected with highhazard viruses: scientific basis for infection controls. Arch. Virol. Suppl. 1996; 11: 141-168. Go to original source...
    2. Marty AM, Jahrling PB, Geisbert TW. Viral hemorrhagic fevers. Clin. Lab. Med. 2006; 26: 345-386. Go to original source... Go to PubMed...
    3. Peters CJ, Zaki SR. Overview of viral hemorrhagic fevers. In: Guerrant RL, Walker DH, Weller PF. Tropical infectious diseases: principles, pathogens and practice. Philadelphia: Churchill Livingstone 2006; 756-761. Go to original source...
    4. McCormick JB, Fisher-Hoch SP. Lassa fever. Curr. Top Microbiol. Immunol. 2002; 262: 75-109. Go to original source... Go to PubMed...
    5. Guerrant RL, Walker DH, Weller PF. Tropical infectious diseases: principles, pathogens and practice. Philadelphia: Churchill Livingstone 2006; 756-761.
    6. Mupapa K, Massamba M, Kibadi, et al. Treatment of Ebola hemorrhagic fever with blood transfusion from convalescent patients. J. Infect. Dis. 1999; S.1: S18-S23. Go to original source... Go to PubMed...
    7. Ozkurt Z, Kiki I, Erol S, et al. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J. Infect. 2006; 52: 207-215. Go to original source... Go to PubMed...
    8. Monath TP, Newhouse VF, Kemp GE, et al. Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science 1974; 185: 263-265. Go to original source... Go to PubMed...
    9. Vapalahti O, Mustonen J, Lundkvist A, et al. Hantavirus infections in Europe. Lancet Infect. Dis. 2003; 3: 653-661. Go to original source... Go to PubMed...
    10. Pejcoch M. Hantaviry a nákazy jimi vyvolané. Klin. Mikrobiol. Inf. Lek. 2003; 1(9): 4-11.
    11. Khan AS, Sanchez A, Pflieger AK. Filoviral haemorrhagic fevers. Br. Med. Bull. 1998; 54(3): 675-692. Go to original source... Go to PubMed...
    12. Lub M, Sergeev AN, Plankova OG, et al. Clinical-virusological characteristics of disease in monkeys in infected with the Marburg virus by an airborne route. Vopr. Virusol. 1995; 40(3): 119-121. Go to PubMed...
    13. Leffel EK, Reed DS. Marburg and Ebola viruses as aerosol threats. Biosec. Bioterr.: Biodefense Strat. Pract. Sci. 2004; 2(3): 1-6. Go to original source...
    14. Haas WH, Breuer T, Pfaff G, et al. Imported Lassa and management of contact persons. Clin. Infect. Dis. 2003; 36(10): 1254-1258. Go to original source... Go to PubMed...
    15. Demby AH, Chamberlain J, Brown DW, Clegg CS. Early diagnosis of Lassa fever by reverse transcription PCR. J. Clin. Microbiol. 1994; 32(12): 2898-2903. Go to original source... Go to PubMed...
    16. Jones SM, Feldmann H, Stroher U, et al. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat. Med. 2005; 11(7): 786-790. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.